NCT00002259View on ClinicalTrials.gov

Phase II Study of Intravenous Novantrone(R) in the Treatment of AIDS Related Kaposi's Sarcoma

PHASE2CompletedINTERVENTIONAL
Timeline

Start Date

Not specified

Conditions
Sarcoma, KaposiHIV Infections
Interventions
DRUG

Mitoxantrone hydrochloride

Trial Locations (1)

10019

Saint Luke's - Roosevelt Hosp Ctr, New York

Sponsors
All Listed Sponsors
lead

Lederle Laboratories

INDUSTRY

NCT00002259 - Phase II Study of Intravenous Novantrone(R) in the Treatment of AIDS Related Kaposi's Sarcoma | Biotech Hunter | Biotech Hunter